Form 4 for IDXX Idexx Laboratories
Accepted 2026-09-09 17:00:08 ET · period of report 2026-09-04 · accession 0000874716-26-000127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-09 17:00 | 2026-09-04 | IDXX | Kingsley Lawrence D | Dir | M - OptEx | $114.17 | +2,203 | 11.8K | +23% | +$251.5K |
| D | 2026-09-09 17:00 | 2026-09-04 | IDXX | Kingsley Lawrence D | Dir | S - Sale+OE | $532.08 | -2,203 | 9,568 | -19% | -$1.17M |
| D | 2026-09-09 17:00 | 2026-09-04 | IDXX | Kingsley Lawrence D | Dir | M - OptEx | — | -2,203 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-04 | M | A | 2,203 | $114.17 | 11,771 | D | — | — | |
| 2 | Common | Common Stock | 2026-09-04 | S | D | 2,203 | $532.08 | 9,568 | D | — | — | (F1) Represents the weighted average price of the shares sold ranging from a low of $531.88 to a high of $532.14 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 3 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2026-09-04 | M | D | 2,203 | — | 0 | D | $114.17 · — to 2026-11-30 | 2,203 Common Stock | (F3) Not applicable. (F2) Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2017. |